- Home
- EOLS vs DLY Comparison
EOLS vs DLY Comparison
Compare EOLS & DLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EOLS
- DLY
- Stock Information
- Founded
- EOLS 2012
- DLY 2019
- Country
- EOLS United States
- DLY United States
- Employees
- EOLS N/A
- DLY N/A
- Industry
- EOLS Biotechnology: Pharmaceutical Preparations
- DLY Investment Managers
- Sector
- EOLS Health Care
- DLY Finance
- Exchange
- EOLS Nasdaq
- DLY Nasdaq
- Market Cap
- EOLS N/A
- DLY 703.9M
- IPO Year
- EOLS 2018
- DLY N/A
- Fundamental
- Price
- EOLS $10.09
- DLY $15.46
- Analyst Decision
- EOLS Strong Buy
- DLY
- Analyst Count
- EOLS 5
- DLY 0
- Target Price
- EOLS $23.75
- DLY N/A
- AVG Volume (30 Days)
- EOLS 965.6K
- DLY 215.9K
- Earning Date
- EOLS 05-07-2025
- DLY 01-01-0001
- Dividend Yield
- EOLS N/A
- DLY 8.93%
- EPS Growth
- EOLS N/A
- DLY N/A
- EPS
- EOLS N/A
- DLY N/A
- Revenue
- EOLS $275,463,000.00
- DLY N/A
- Revenue This Year
- EOLS $34.44
- DLY N/A
- Revenue Next Year
- EOLS $33.00
- DLY N/A
- P/E Ratio
- EOLS N/A
- DLY N/A
- Revenue Growth
- EOLS 25.38
- DLY N/A
- 52 Week Low
- EOLS $8.67
- DLY $13.26
- 52 Week High
- EOLS $17.82
- DLY $15.95
- Technical
- Relative Strength Index (RSI)
- EOLS 38.22
- DLY 55.99
- Support Level
- EOLS $11.15
- DLY $15.31
- Resistance Level
- EOLS $12.16
- DLY $15.49
- Average True Range (ATR)
- EOLS 0.62
- DLY 0.19
- MACD
- EOLS 0.06
- DLY 0.10
- Stochastic Oscillator
- EOLS 6.81
- DLY 95.70
About DLY DoubleLine Yield Opportunities Fund of Beneficial Interest
DoubleLine Yield Opportunities Fund is a diversified, limited-term, closed-end management investment company. Its investment objective is to seek a high level of total return, with an emphasis on current income. The company invests in debt securities and other income-producing investments of issuers anywhere in the world, including in emerging markets, and may invest in investments of any credit quality. Its investment portfolio comprises foreign corporate bonds, foreign government bonds, non-agency commercial mortgage-backed obligations, U.S. corporate bonds, collateralized loan obligations, and bank loans among other securities.